FDA Approval


Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

This week, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in the treatment of rare genetic diseases surrounding obesity, announced the U.S. Food & Drug Administration’s (FDA) approval of their new drug, IMCIVREE™(setmelanotide). IMCIVREE is used...

FDA Approves a Record Number of Drug Approvals

The United States Food and Drug Administration (FDA) set a record this year in new drug approvals including multiple innovative cancer and HIV drugs.  In 2018 the FDA approved 59 new molecular entities in 2018—a two-decade record, according to the database of the...

Pin It on Pinterest